YAZ Post-marketing Surveillance in Japan

CompletedOBSERVATIONAL
Enrollment

3,273

Participants

Timeline

Start Date

June 9, 2011

Primary Completion Date

December 5, 2017

Study Completion Date

March 8, 2018

Conditions
Dysmenorrhea
Interventions
DRUG

EE20/DRSP(YAZ, BAY86-5300)

Patients in daily life treatment receiving YAZ for dysmenorrhea.

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY